Charing Cross (CX) International Symposium 2020

Charing Cross (CX) International Symposium is organized by BIBA Medical Ltd and will be held from Apr 21 - 24, 2020 at Olympia London, London, England, United Kingdom.

Description:
The Charing Cross Symposium 2020, London, is a vascular and endovascular annual meeting where Education, Innovation and Evidence come together.

CX 2020 will conclude another cycle of Controversies, Challenges and Consensus, with this year focusing on Consensus. In 2020, we introduce a new session, Major Vascular Trauma, including talks on aortic, pelvis and extremity, and neck trauma.

With a fantastic programme covering the core topics of Aortic, Peripheral Arterial, Venous & Lymphatic, Acute Stroke, Vascular Access and iWounds, the CX Symposium approach has always been to promote Education, Innovation, and Evidence, with a strong focus on audience participation and Q&A. In addition to traditional learning through talks and presentations, we pride ourselves on our free-for-all our hands-on workshops, designed to improve your knowledge of the latest devices and techniques, leading to better patient outcomes in your place of work.

At CX 2019 attendees could receive up to 28 CME points.

We look forward to welcoming you to CX 2020!

CX 2020 Preliminary Programme Highlights:
Peripheral Proximal Arterial Ischaemia Consensus – Tuesday 21 April 2020  
• Update on the paclitaxel controversy in the lower limb
• Alternatives to paclitaxel coating to reduce restenosis
• The evidence for vessel preparation in the superficial femoral artery
• An RCT comparing conventional versus ambulatory for endovascular procedures of lower extremity peripheral artery disease
• Debate—Common femoral artery disease occlusion: The ostium of the profunda femoris artery should be treated with open surgery
• Peripheral Arterial Podium 1st trials

Peripheral Critical Ischaemia Consensus – Thursday 23 April 2020 
• Outcome of revascularisation for chronic limb–threatening limb ischaemia can be predicted
• Perfusion analysis of the foot in patients with critical limb ischaemia before and after revascularisation
• New diagnostic tools for critical limb ischaemia patients
• Patient selection for deep venous arterialisation in small vessel disease

Abdominal Aortic Consensus – Wednesday 22 April 2020 
• Sac Growth Algorithm Study in the community
• Centralisation of abdominal aortic aneurysm care improves early clinical outcomes
• Routine embolisation of the inferior mesenteric artery with EVAR 
• Differences in size of abdominal aortic aneurysm in nine countries and impact on rupture rates
• The ESVS 2019 Abdominal Aortic Aneurysm guidelines
• Debate—Threshold for intervention in iliac artery aneurysms
• Aortic Podium 1st trials

Thoracic Aortic Consensus – Thursday 23 April 2020 
• Stroke from Thoracic Endovascular Procedures (STEP)
• Debate: Timing of intervention for acute type B dissection
• Single fenestrated endografts for the left sub clavian artery vs carotid-sub clavian bypass and standard TEVAR 
• Debate—Upper extremity access should be avoided in complex endovascular aortic repair 
• Strategies to prevent spinal cord injury
• Endovascular team radiation safety performance

Venous & Lymphatic Consensus – Tuesday 21 April 2020  
• Final three-year results of a randomised controlled trial comparing endovenous laser ablation and foam in SSV insufficiency 
• Consensus on pelvic vein incompetence management
• Management of lipoedema and lymphoedema
• Anatomical classification of chronic venous obstruction and its implications
• Optimising patient selection in the treatment of non-thrombotic iliac vein lesions
• Medical therapy after deep venous interventions
• Venous Podium 1st trials

Acute Stroke Consensus – Friday 24 April 2020  
• International variation in carotid surgery is huge despite all the randomised trials performed
• Debate-Atrial fibrillation influences whether you should operate in asymptomatic carotid stenosis
• Intervention in carotid artery aneurysms:Indications and techniques 
• Complex carotid body tumours and adjunctive endovascular treatment
• Debate—Only extra cranial vertebral arteries should be considered for stenting

Vascular Access Masterclass – Wednesday 22 April 2020  
• The access algorithm: Can we define an algorithmic approach to vascular access preservation and maintenance?
• Pre-operative vein enhancement, assessment and planning
• Fistula formation: Surgical fistula and endoAVF
• Panel discussion: How do we train the whole of the team in vascular access? 
• Drug-coated balloon in vascular access trial update
• Vascular Access Podium 1st trials

iWounds Consensus – Wednesday 22 April 2020  
• The importance of underlying diagnosis in the management of all leg wounds and ulcers
• The value of specialist nursing and care
• Challenges and solutions of providing evidenced based leg ulcer care
• The need for integrated care in the management of diabetic foot ulcers
• Modern wound dressings and techniques

NEW: Major Vascular Trauma – Wednesday 22 April 2020 
• Damage control surgery for vascular surgeons 
• Catastrophic vascular haemorrhage: Pelvic exsanguination
• Blunt aortic injury– when to intervene, landing zones, debranching, and surveillance 
• Extremity vascular trauma
• Management of neck trauma– worst day at the office 

Workshop schedule:
• CX Venous Workshop: Wednesday 22 and Thursday 23 April
• CX iWounds Workshop: Wednesday 22 and Thursday 23 April
• CX Peripheral Workshop: Tuesday 22 and Wednesday 23 April 10.00-16.00
• CX Aortic Workshop: Tuesday 22 and Wednesday 23 April 10.00-16.00
• CX Vascular Access Workshop: Thursday 23 April 10.00-16.00

Additional details will be posted as soon as information is available.